Search Prime Grants

UH3MH120094

Cooperative Agreement

Overview

Grant Description
A massive library of AAVs to target transcriptionally-defined primate cell types - here we will identify nonhuman primate (NHP) neuron types and build an extensive toolbox of vectors for circuit-based neuroscience studies.

NHPs share substantial neuroanatomical, genetic, and behavioral homology with humans, and therefore they are indispensable for investigating the neural circuit basis of cognition and devising therapies to treat neurological and psychiatric disorders.

Despite the importance of NHPs, we lack the tools to analyze and manipulate complex circuits in the primate brain. This lack severely limits the use of genetically-coded neuroscience tools to examine circuit specific functions and hinders development of targeted gene therapeutics.

Current methods for achieving transgenesis in small model species, such as the creation of genetically modified strains, are prohibitively expensive in NHP and not applicable to human disease.

AAVs are the leading alternative to germline modification and selective breeding. AAVs infect adult neurons, confer stable transgene expression, and have proven safe in gene therapy clinical trials.

AAVs do not have natural cell-types specific properties, but when altered or combined with cell type specific regulatory sequences (enhancers/promoters) they have been able to achieve cell type-specific transgenesis. This has made possible, for example, our previous optogenetic investigation of midbrain dopamine neurons for learning and decision making.

However, before AAV-mediated gene delivery can be generalized to circuits across the brain and for multiple behavioral functions, we must create currently lacking vectors and promoters that permit efficient and specific gene delivery to all required cell types.

Here, we will combine single-cell RNA-seq (scRNA-seq) with high-throughput screening of engineered adeno-associated viruses (AAVs) to create a complete toolbox of viral vectors and promoters enabling minimally invasive monitoring and manipulation of neurons in NHP brain.

We have devised a transdisciplinary approach to classify individual neurons according to their gene expression profile and simultaneously screen for adeno-associated virus (AAV) vectors (capsids and regulatory sequences) capable of specific and efficient transgene delivery to classified neurons.

First, we will synthesize massive libraries of mutated AAV vectors and synthetic promoters, in which each variant is paired with a unique DNA barcode. We will then scRNA-seq to capture the transcriptome for each cell and quantify the AAV and promoter-specific barcodes in every cell's expression profile.

Preliminary experiments in rhesus monkeys have fully validated and demonstrated the promise of this innovative approach.

The outcomes of our specific aims will include (1) an inventory of cell types in the retina, prefrontal cortex, primary motor cortex, and striatum, (2) cell type-specific AAVs and promoters targeting all defined cell types, (3) AAVs with broad tropisms, (4) a publicly available dataset of transcription profiles for millions of NHP brain cells, (5) an updated and comprehensive rhesus macaque reference genome, and (6) anatomical, physiological, and functional validation of cell type-specific circuits tools and their function in the NHP brain.
Funding Goals
NOT APPLICABLE
Place of Performance
Pittsburgh, Pennsylvania 15213 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 74% from $1,808,049 to $3,150,167.
University Of Pittsburgh - Of The Commonwealth System Of Higher Education was awarded Primate Cell Type Targeting Toolbox: AAV-Based Neuroscience Study Cooperative Agreement UH3MH120094 worth $3,150,167 from the National Institute of Mental Health in September 2019 with work to be completed primarily in Pittsburgh Pennsylvania United States. The grant has a duration of 6 years and was awarded through assistance program 93.242 Mental Health Research Grants. The Cooperative Agreement was awarded through grant opportunity BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 9/5/24

Period of Performance
9/1/19
Start Date
8/31/25
End Date
100.0% Complete

Funding Split
$3.2M
Federal Obligation
$0.0
Non-Federal Obligation
$3.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UH3MH120094

Subgrant Awards

Disclosed subgrants for UH3MH120094

Transaction History

Modifications to UH3MH120094

Additional Detail

Award ID FAIN
UH3MH120094
SAI Number
UH3MH120094-1346859420
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Other
Awarding Office
75N700 NIH NATIONAL INSTITUTE OF MENTAL HEALTH
Funding Office
75N700 NIH NATIONAL INSTITUTE OF MENTAL HEALTH
Awardee UEI
MKAGLD59JRL1
Awardee CAGE
1DQV3
Performance District
PA-12
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Mental Health, National Institutes of Health, Health and Human Services (075-0892) Health research and training Grants, subsidies, and contributions (41.0) $1,808,049 100%
Modified: 9/5/24